NDC-11 (Package) | NDC-9 (Product) | Generic Name | Brand Name (Ascending) | Strength | SEER*Rx Category | Major Class | Minor Class | Administration Route | Package Effective Date | Package Discontinuation Date | Status |
---|---|---|---|---|---|---|---|---|---|---|---|
43063-0383-15 | 43063-0383 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Aug. 20, 2012 | In Use | ||
59651-0236-30 | 59651-0236 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | July 24, 2020 | In Use | ||
59651-0236-90 | 59651-0236 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | July 24, 2020 | In Use | ||
63629-5269-00 | 63629-5269 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Jan. 5, 2021 | In Use | ||
63629-5269-01 | 63629-5269 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | March 21, 2014 | In Use | ||
63629-5269-02 | 63629-5269 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Aug. 13, 2014 | In Use | ||
63629-5269-03 | 63629-5269 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Jan. 26, 2016 | In Use | ||
63629-5269-04 | 63629-5269 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | June 20, 2018 | In Use | ||
63629-5269-05 | 63629-5269 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Dec. 1, 2021 | In Use | ||
63629-5269-06 | 63629-5269 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | June 25, 2018 | In Use | ||
63629-5269-07 | 63629-5269 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Nov. 20, 2019 | In Use | ||
63629-5269-08 | 63629-5269 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | March 6, 2019 | In Use | ||
63629-5269-09 | 63629-5269 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | July 7, 2020 | In Use | ||
00054-0164-13 | 00054-0164 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | June 28, 2010 | March 8, 2018 | No Longer Used | |
00093-7536-56 | 00093-7536 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | June 28, 2010 | In Use | ||
00115-1261-01 | 00115-1261 | Anastrozole | Anastrozole | Hormonal Therapy | Aromatase Inhibitor | Oral | June 5, 2013 | Aug. 26, 2013 | No Longer Used | ||
00115-1261-03 | 00115-1261 | Anastrozole | Anastrozole | Hormonal Therapy | Aromatase Inhibitor | Oral | June 5, 2013 | Aug. 26, 2013 | No Longer Used | ||
00115-1261-08 | 00115-1261 | Anastrozole | Anastrozole | Hormonal Therapy | Aromatase Inhibitor | Oral | June 5, 2013 | Aug. 26, 2013 | No Longer Used | ||
00115-1261-10 | 00115-1261 | Anastrozole | Anastrozole | Hormonal Therapy | Aromatase Inhibitor | Oral | June 5, 2013 | Aug. 26, 2013 | No Longer Used | ||
00904-6195-46 | 00904-6195 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | June 15, 2010 | In Use | ||
42043-0180-03 | 42043-0180 | Anastrozole | Anastrozole | Hormonal Therapy | Aromatase Inhibitor | Oral | June 28, 2010 | April 30, 2012 | No Longer Used | ||
42291-0105-30 | 42291-0105 | Anastrozole | Anastrozole | Hormonal Therapy | Aromatase Inhibitor | Oral | June 28, 2010 | Dec. 12, 2011 | No Longer Used | ||
54569-6198-00 | 54569-6198 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | May 9, 2016 | In Use | ||
60258-0866-03 | 60258-0866 | Anastrozole | Anastrozole | Hormonal Therapy | Aromatase Inhibitor | Oral | June 28, 2010 | Sept. 11, 2013 | No Longer Used | ||
62033-0376-06 | 62033-0376 | Anastrozole | Anastrozole | Hormonal Therapy | Aromatase Inhibitor | Oral | March 31, 2011 | In Use | |||
65841-0743-06 | 65841-0743 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | June 27, 2010 | In Use | ||
65841-0743-10 | 65841-0743 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | June 27, 2010 | In Use | ||
68001-0155-04 | 68001-0155 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Jan. 1, 2014 | In Use | ||
68001-0155-08 | 68001-0155 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Jan. 1, 2014 | In Use | ||
68382-0209-06 | 68382-0209 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | June 27, 2010 | In Use | ||
68382-0209-10 | 68382-0209 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | June 27, 2010 | In Use | ||
68084-0448-11 | 68084-0448 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | June 27, 2010 | Jan. 31, 2017 | No Longer Used | |
68084-0448-21 | 68084-0448 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | June 27, 2010 | Jan. 31, 2017 | No Longer Used | |
69117-0003-01 | 69117-0003 | Anastrozole Tablets | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Feb. 28, 2019 | In Use | ||
69117-0003-04 | 69117-0003 | Anastrozole Tablets | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Feb. 28, 2019 | In Use | ||
00378-6034-05 | 00378-6034 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | June 28, 2010 | Sept. 30, 2013 | No Longer Used | |
00378-6034-77 | 00378-6034 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | June 28, 2010 | Dec. 31, 2013 | No Longer Used | |
00378-6034-93 | 00378-6034 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | June 28, 2010 | Dec. 31, 2013 | No Longer Used | |
00187-0902-01 | 00187-0902 | Methyltestosterone | Android | 10.0 mg/1 | Hormonal Therapy | Androgen | Oral | Dec. 3, 1973 | April 30, 2018 | No Longer Used | |
00832-0086-00 | 00832-0086 | Fluoxymesterone | Androxy | 10.0 mg/1 | Hormonal Therapy | Androgen | Oral | Oct. 21, 1983 | In Use | ||
00088-1202-05 | 00088-1202 | Dolasetron mesylate | Anzemet | 50.0 mg/1 | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | Sept. 11, 1997 | June 30, 2017 | No Longer Used |
00088-1202-43 | 00088-1202 | Dolasetron mesylate | Anzemet | 50.0 mg/1 | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | Sept. 11, 1997 | Aug. 31, 2011 | No Longer Used |
00088-1203-05 | 00088-1203 | Dolasetron mesylate | Anzemet | 100.0 mg/1 | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | Sept. 11, 1997 | June 30, 2017 | No Longer Used |
00088-1203-29 | 00088-1203 | Dolasetron mesylate | Anzemet | 100.0 mg/1 | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | Sept. 11, 1997 | March 31, 2006 | No Longer Used |
00088-1203-43 | 00088-1203 | Dolasetron mesylate | Anzemet | 100.0 mg/1 | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | Sept. 11, 1997 | Oct. 31, 2012 | No Longer Used |
00088-1206-32 | 00088-1206 | Dolasetron mesylate | Anzemet | 100.0 mg/5mL | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Intravenous | Sept. 11, 1997 | Sept. 30, 2017 | No Longer Used |
00088-1208-06 | 00088-1208 | Dolasetron mesylate | Anzemet | 12.5 mg/.625mL | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Intravenous | Sept. 11, 1997 | Aug. 31, 2016 | No Longer Used |
00088-1208-76 | 00088-1208 | Dolasetron mesylate | Anzemet | 12.5 mg/.625mL | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Intravenous | Sept. 11, 1997 | Nov. 9, 2012 | No Longer Used |
00088-1209-26 | 00088-1209 | Dolasetron mesylate | Anzemet | 500.0 mg/25mL | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Intravenous | Sept. 11, 1997 | June 30, 2016 | No Longer Used |
30698-0120-05 | 30698-0120 | Dolasetron mesylate | Anzemet | 50.0 mg/1 | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | Sept. 11, 1997 | May 24, 2021 | In Use |
30698-0121-05 | 30698-0121 | Dolasetron mesylate | Anzemet | 100.0 mg/1 | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | Sept. 11, 1997 | May 24, 2021 | In Use |
69189-0679-01 | 69189-0679 | Dolasetron mesylate | Anzemet | 100.0 mg/1 | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | July 26, 2016 | May 24, 2017 | No Longer Used |
54868-4138-00 | 54868-4138 | Dolasetron mesylate | Anzemet | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | Sept. 11, 1997 | June 30, 2010 | No Longer Used | |
54868-4138-01 | 54868-4138 | Dolasetron mesylate | Anzemet | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | Sept. 11, 1997 | June 30, 2010 | No Longer Used | |
82737-0073-01 | 82737-0073 | Motixafortide | Aphexda | 62.0 mg/1.7mL | Ancillary Therapy | Immunostimulant | Stem cell mobilizer | Subcutaneous | Sept. 8, 2023 | In Use | |
70383-0073-01 | 70383-0073 | MOTIXAFORTIDE ACETATE | Aphexda | 62.0 mg/1.7mL | Ancillary Therapy | Immunostimulant | Stem cell mobilizer | Subcutaneous | Sept. 8, 2023 | In Use | |
00781-2321-06 | 00781-2321 | Aprepitant | Aprepitant | 40.0 mg/1 | Ancillary Therapy | Antiemetic | Substance P/Neurokinin 1 | Oral | Dec. 27, 2016 | In Use | |
00781-2321-51 | 00781-2321 | Aprepitant | Aprepitant | 40.0 mg/1 | Ancillary Therapy | Antiemetic | Substance P/Neurokinin 1 | Oral | Dec. 27, 2016 | In Use | |
00781-2322-46 | 00781-2322 | Aprepitant | Aprepitant | 80.0 mg/1 | Ancillary Therapy | Antiemetic | Substance P/Neurokinin 1 | Oral | Dec. 27, 2016 | In Use | |
00781-2322-68 | 00781-2322 | Aprepitant | Aprepitant | 80.0 mg/1 | Ancillary Therapy | Antiemetic | Substance P/Neurokinin 1 | Oral | Dec. 27, 2016 | In Use | |
00781-2323-68 | 00781-2323 | Aprepitant | Aprepitant | 125.0 mg/1 | Ancillary Therapy | Antiemetic | Substance P/Neurokinin 1 | Oral | Dec. 27, 2016 | In Use | |
00781-4063-36 | 00781-4063 | Aprepitant | Aprepitant | Ancillary Therapy | Antiemetic | Substance P/Neurokinin 1 | Dec. 27, 2016 | In Use | |||
55513-0002-01 | 55513-0002 | Darbepoetin alfa | Aranesp | 25.0 ug/mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Sept. 11, 2006 | In Use | ||
55513-0002-04 | 55513-0002 | Darbepoetin alfa | Aranesp | 25.0 ug/mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Sept. 11, 2006 | In Use | ||
55513-0003-01 | 55513-0003 | Darbepoetin alfa | Aranesp | 40.0 ug/mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Sept. 11, 2006 | In Use | ||
55513-0003-04 | 55513-0003 | Darbepoetin alfa | Aranesp | 40.0 ug/mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Sept. 11, 2006 | In Use | ||
55513-0004-01 | 55513-0004 | Darbepoetin alfa | Aranesp | 60.0 ug/mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Sept. 11, 2006 | In Use | ||
55513-0004-04 | 55513-0004 | Darbepoetin alfa | Aranesp | 60.0 ug/mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Sept. 11, 2006 | In Use | ||
55513-0021-01 | 55513-0021 | Darbepoetin alfa | Aranesp | 40.0 ug/.4mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Feb. 18, 2011 | In Use | ||
55513-0021-04 | 55513-0021 | Darbepoetin alfa | Aranesp | 40.0 ug/.4mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Aug. 14, 2006 | In Use | ||
55513-0023-01 | 55513-0023 | Darbepoetin alfa | Aranesp | 60.0 ug/.3mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Feb. 18, 2011 | In Use | ||
55513-0023-04 | 55513-0023 | Darbepoetin alfa | Aranesp | 60.0 ug/.3mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Aug. 14, 2006 | In Use | ||
55513-0025-01 | 55513-0025 | Darbepoetin alfa | Aranesp | 100.0 ug/.5mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Feb. 18, 2011 | In Use | ||
55513-0025-04 | 55513-0025 | Darbepoetin alfa | Aranesp | 100.0 ug/.5mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Aug. 14, 2006 | In Use | ||
55513-0057-01 | 55513-0057 | Darbepoetin alfa | Aranesp | 25.0 ug/.42mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Feb. 18, 2011 | In Use | ||
55513-0057-04 | 55513-0057 | Darbepoetin alfa | Aranesp | 25.0 ug/.42mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Aug. 26, 2006 | In Use | ||
55513-0098-01 | 55513-0098 | Darbepoetin alfa | Aranesp | 10.0 ug/.4mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Oct. 6, 2015 | In Use | ||
55513-0098-04 | 55513-0098 | Darbepoetin alfa | Aranesp | 10.0 ug/.4mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Aug. 26, 2006 | In Use | ||
55513-0005-01 | 55513-0005 | Darbepoetin alfa | Aranesp | 100.0 ug/mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Sept. 11, 2006 | In Use | ||
55513-0005-04 | 55513-0005 | Darbepoetin alfa | Aranesp | 100.0 ug/mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Sept. 11, 2006 | In Use | ||
55513-0027-01 | 55513-0027 | Darbepoetin alfa | Aranesp | 150.0 ug/.3mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Feb. 18, 2011 | In Use | ||
55513-0027-04 | 55513-0027 | Darbepoetin alfa | Aranesp | 150.0 ug/.3mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Sept. 11, 2006 | In Use | ||
55513-0014-01 | 55513-0014 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Oct. 1, 2001 | Feb. 28, 2009 | No Longer Used | |||
55513-0015-01 | 55513-0014 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Aug. 19, 2002 | April 30, 2009 | No Longer Used | |||
55513-0039-01 | 55513-0039 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Feb. 18, 2011 | Feb. 28, 2009 | No Longer Used | |||
55513-0039-04 | 55513-0039 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | July 23, 2003 | Feb. 28, 2009 | No Longer Used | |||
55513-0041-01 | 55513-0041 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Feb. 18, 2011 | Feb. 28, 2009 | No Longer Used | |||
55513-0041-04 | 55513-0041 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | July 23, 2003 | Feb. 28, 2009 | No Longer Used | |||
55513-0043-01 | 55513-0043 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Feb. 18, 2011 | Dec. 31, 2008 | No Longer Used | |||
55513-0043-04 | 55513-0043 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | June 1, 2004 | Dec. 31, 2008 | No Longer Used | |||
55513-0044-01 | 55513-0044 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Feb. 18, 2011 | Feb. 28, 2009 | No Longer Used | |||
55513-0044-04 | 55513-0044 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | July 23, 2003 | Feb. 28, 2009 | No Longer Used | |||
55513-0046-01 | 55513-0046 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Feb. 18, 2011 | April 30, 2009 | No Longer Used | |||
55513-0046-04 | 55513-0046 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | July 23, 2003 | April 30, 2009 | No Longer Used | |||
54868-5428-00 | 54868-5428 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Sept. 13, 2006 | June 30, 2013 | No Longer Used | |||
54868-5429-00 | 54868-5429 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | March 20, 2008 | June 30, 2013 | No Longer Used | |||
54868-5867-00 | 54868-5867 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | March 20, 2008 | June 30, 2013 | No Longer Used | |||
55513-0006-01 | 55513-0006 | Darbepoetin alfa | Aranesp | 200.0 ug/mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Sept. 11, 2006 | In Use | ||
55513-0010-01 | 55513-0010 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Oct. 1, 2001 | March 31, 2009 | No Longer Used | |||
55513-0010-04 | 55513-0010 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Oct. 1, 2001 | March 31, 2009 | No Longer Used |
Found 10,000 results in 5 milliseconds — Export these results